[144] Gevo, Inc. SEC Filing

Rhea-AI Filing Summary

Gevo, Inc. has filed a Form 144 proposing the sale of 200,000 shares of common stock through Stifel Nicolaus, with an aggregate market value of $389,680 and an approximate sale date of 08/12/2025 on Nasdaq. The filing reports 241,839,083 shares outstanding, which provides context for the proposed sale size relative to the company's share base.

The securities to be sold were acquired as equity compensation: 100,000 shares from an options exercise dated 05/23/2024 and 100,000 shares from restricted stock awards dated 10/15/2023 (with a noted payment date of 10/15/2024). The filer also represents they are not aware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: A routine Form 144 discloses an insider sale of 200,000 Gevo shares; size is small relative to the outstanding base.

The proposed sale totals 200,000 common shares with an aggregate market value of $389,680 against 241.84 million shares outstanding, implying a de minimis dilution impact (~0.083%). The shares originate from equity compensation events (options exercise and restricted stock awards), not from secondary transactions involving third-party transfers. From a trading-impact perspective, the filing alone is unlikely to move markets given the small absolute dollar size and the brokered arrangement through Stifel Nicolaus.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; the filing affirms standard insider representation about material non-public information.

The Form 144 includes the standard representation that the seller does not possess undisclosed material adverse information and lists acquisition details for the securities, consistent with compliance expectations for reporting sales by affiliates. The securities were obtained via equity compensation, which may reflect normal executive vesting and exercise activity rather than a governance concern. No related-party aggregation or recent sales in the prior three months were reported.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	200000	389680.00	241839083	08/12/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/23/2024	Options Exercise	Issuer			100000	08/12/2025	Equity Compensation
Common Stock	10/15/2023	Restricted Stock Awards	Issuer			100000	10/15/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Gevo (GEVO) disclose in this Form 144?

The filing proposes the sale of 200,000 common shares via Stifel Nicolaus with an aggregate market value of $389,680 and an approximate sale date of 08/12/2025.

How many shares outstanding did the filing report for GEVO?

The Form 144 lists 241,839,083 shares outstanding.

How were the securities being sold acquired?

The securities were acquired as equity compensation: 100,000 from an options exercise dated 05/23/2024 and 100,000 from restricted stock awards dated 10/15/2023 (payment date noted as 10/15/2024).

Who is the broker named in the Form 144 for the proposed sale?

The broker named is Stifel Nicolaus & Company Inc, address listed as 501 N Broadway, St. Louis, MO 63102.

Does the filing report any securities sold by the filer in the past three months?

The Form 144 indicates "Nothing to Report" for securities sold during the past three months.